News

Milemarker Unveils DevTools: Accelerating Wealth Management Solutions

Milemarker Unveils DevTools: Accelerating Wealth Management Solutions

Milemarker Launches Innovative DevTools for Wealth Management

Milemarker has introduced its new DevTools, a powerful command-line toolkit aimed at revolutionizing the way wealth management firms handle analytics and data automation. This groundbreaking solution enables firms to deploy essential metrics, analytics, and insights in mere minutes instead of the traditional weeks-long processes.

Eliminating Bottlenecks

According to Kailash Duraiswami, the CTO of Milemarker, this technology addresses long-standing challenges within wealth management firms, particularly the bottlenecks that develop between engineering, operations, and advisory teams. "With DevTools, we empower engineers and operations professionals to deploy new queries, projections, and metrics directly into production without delay or risk. This level of control allows teams to obtain accurate answers swiftly, maintaining compliance at the same time," he explained.

Key Features of Milemarker DevTools

Milemarker DevTools offers a suite of powerful capabilities that enhance efficiency:

  • One-Command Deployments: Users can push queries, metrics, or projections directly from the command line, drastically simplifying the deployment process.
  • Instant Metric Creation: Any query can be transformed into a reusable, canonical Key Performance Indicator (KPI), ensuring consistency across all data dashboards.
  • Custom Search Index: This feature allows for comprehensive searches across extensive data sets, ensuring that advisors and operations teams can find the information they need swiftly.
  • CLI Extensibility: The plugin architecture supports customization, enabling firms to adapt DevTools to their specific workflows.
  • Scalability: Designed to grow alongside firms, the toolkit maintains performance even as data volumes increase.

Commitment to Security and Compliance

DevTools prioritizes security and compliance by integrating with enterprise identity systems through Role-Based Access Control (RBAC) and Single Sign-On (SSO). Additionally, it employs parameterized secrets management with Vault and Key Management Services (KMS). The upcoming feature of a full audit trail for CLI actions ensures that firms can move swiftly while still adhering to rigorous governance standards.

Industry Validation

Adoption of DevTools has already garnered positive feedback from industry leaders. Jordan Hutchison, Ph.D., the VP of Technology and Operations at RFG Advisory, remarked on its transformative effect: "This tool has revolutionized our approach to data orchestration and delivery. It allows us to unify our previously siloed systems into a seamless framework, significantly enhancing our operational efficiency and responsiveness to client needs."

Optimal Applications for DevTools

There are several ideal use cases for Milemarker DevTools:

  • Wealth-tech platforms aiming for rapid metric iterations.
  • Registered Investment Advisors (RIAs) consolidating diverse data sources following mergers or acquisitions.
  • Asset management entities deploying performance dashboards for advisors.

Technical Specifications of Milemarker DevTools

The following are key technical specifications of the DevTools:

  • Programming Languages: SQL and Python
  • Data Warehouses: Primarily Snowflake, supplemented by Postgres
  • Query Engine: Integrated with Apache Spark along with native Snowflake computing capabilities
  • Supported Platforms: Compatible with MacOS, Windows, and Linux (x86 & ARM)
  • Version Control: Encourages Git integration with semantic release tagging

Milemarker DevTools is now available for wealth management firms eager to streamline their analytics and automation processes. For more information or to request access, visit www.milemarker.co.

About Milemarker

Milemarker serves as a comprehensive fintech platform, uniquely designed to unify the disparate technology systems employed by wealth management entities. Tailored for Registered Investment Advisors (RIAs), broker-dealers, Turnkey Asset Management Platforms (TAMPs), and wealth management aggregators, Milemarker effectively abolishes the hidden costs associated with tech fragmentation. By consolidating critical data into a single repository and integrating seamlessly with over 130 industry systems—from Customer Relationship Management (CRM) solutions to custodians and billing software—Milemarker ensures smooth data flows, eliminating manual intervention. All client information is housed in a secure, SOC 2 Type II-certified data warehouse, providing top-tier security and compliance. By synthesizing data from various sources, Milemarker delivers a unified source of truth that allows teams to focus on client service rather than administrative data management.

With headquarters in Charleston, S.C., the company also boasts teams located in several other cities across the U.S., including Denver, Omaha, Atlanta, Cincinnati, and Phoenix.

Frequently Asked Questions

What is Milemarker DevTools?

Milemarker DevTools is a command-line toolkit that enables wealth management firms to deploy analytics and data metrics quickly and efficiently.

Who can benefit from using DevTools?

Wealth management firms, including RIAs, wealth-tech platforms, and asset managers, can significantly benefit from DevTools.

How does Milemarker ensure security and compliance?

DevTools uses RBAC, SSO, Vault/KMS for secret management, and it will soon feature an audit trail of CLI actions to ensure security and compliance.

What capabilities does DevTools offer?

Key capabilities include one-command deployments, instant metric creation, custom search indexing, and scalability with growth.

Where can I access Milemarker DevTools?

Wealth management firms interested in Milemarker DevTools can learn more and request access through the official website at www.milemarker.co.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 159

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 117

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 181

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 469

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

CleanSpark's $550 Million Notes Offering and Strategic Outlook

Updated Category News Views 320

CleanSpark, Inc. Unveils $550 Million Convertible Notes Offering CleanSpark, Inc. (NASDAQ: CLSK), a leader in Bitcoin mining, has announced the successful pricing of a significant offering of $550 million in aggregate principal amount of its 0.00% Convertible Senior Notes due 2030. This endeavor is strategically positioned to enhance the company's financial flexibility...

Continue Reading
Terviva and Idemitsu Team Up for Sustainable Aviation Innovation

Updated Category News Views 203

Terviva Partners with Idemitsu for Sustainable Aviation Fuels Terviva, Inc. is a trailblazer in agricultural innovation, working to cultivate pongamia, a highly sustainable crop, for various applications including food, feed, and fuel. Recently, Terviva has entered into a strategic partnership with Idemitsu Kosan Co., Ltd, a leader in integrated energy, to advance the...

Continue Reading
Transforming Invoice Processing: BERNER Group Adopts xSuite

Updated Category News Views 362

Transforming Invoice Processing at BERNER Group The SAP-certified, highly integrated solution meets all the requirements of German and European legislation on electronic invoices. In a significant move towards modern procurement efficiency, the BERNER Group has chosen to adopt xSuite's AI-driven invoice automation solution. This innovative decision aligns with their...

Continue Reading
Celebrating Gord Hicks: A Commitment to Youth Wellness

Updated Category News Views 265

Honoring Gord Hicks with the King Charles III Coronation Medal Gord Hicks C.M., the CEO of BGIS, has been honored with the King Charles III Coronation Medal, recognizing his extensive commitment to youth mental health advocacy. For a decade, Hicks has actively supported initiatives with Kids Help Phone, contributing significantly to the well-being of young Canadians. The...

Continue Reading
Cellebrite Sees Booming Growth with Higher Price Target Outlook

Updated Category News Views 224

Cellebrite's Growth Prospects Shine Brightly Recently, TD Cowen raised its price target for Cellebrite (NASDAQ: CLBT) shares from $20.00 to $23.00, signaling the company's strong growth potential. This update reflects an optimistic outlook that emerged from recent management discussions, which provided valuable insights into Cellebrite's strategic direction and market...

Continue Reading